Board Meeting Intimation for Consider And Approve Unaudited Financial Result For The Quarter Ended On 31.12.2025
05-Feb-2026 | Source : BSECiturgia Biochemicals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/02/2026 inter alia to consider and approve unaudited financial result for the quarter ended on 31.12.2025
Closure of Trading Window
29-Jun-2019 14:03 | Source : BSEClosure of Trading Window
Reg.24(A)-Annual Secretarial Compliance
30-May-2019 17:50 | Source : BSEAnnual Secretarial Compliance Report
| Sr. No. | Particulars | Details |
| 1 | Period for which the report has been issued | 31/03/2019 |
| 2 | Date of Report | 30/05/2019 |
| 3 | Name of the Certifying Firm | Anand Sharma & Associates |
| 4 | Name of the Certifying Individual | Anand Prakash Sharma |
| 5 | Membership Type | ACS |
| 6 | Membership Number | 2836 |
| 7 | CP No. | 20141 |
| 8 | Whether any observations/qualification reported by the Secretarial Auditor ? | Yes |
Corporate Actions
14 Feb 2026
No Dividend history available
Citurgia Biochemicals Ltd has announced 2:10 stock split, ex-date: 26 Apr 18
No Bonus history available
No Rights history available






